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Bio-Medical
A novel treatment for retinal degener-
ative disorders involving transplantation
of cells into the eye is currently under
development at NASA Ames Research
Center and Stanford University School
of Medicine. The technique uses bucky
paper as a support material for retinal
pigment epithelial (RPE) cells, iris pig-
ment epithelial (IPE) cells, and/or stem
cells.  This technology is envisioned as a
treatment  for age-related macular de-
generation, which is the leading cause of
blindness in persons over age 65 in West-
ern nations.  Additionally, patients with
other retinal degenerative disorders,
such as retinitis pigmentosa, may be
treated by this strategy.
Bucky paper is a mesh of carbon nan-
otubes (CNTs), as shown in Figure 1,
that can be made from any of the com-
mercial sources of CNTs. Bucky paper is
biocompatible and capable of support-
ing the growth of biological cells. Be-
cause bucky paper is highly porous, nu-
trients, oxygen, carbon dioxide, and
waste can readily diffuse through it.
The thickness, density, and porosity of
bucky paper can be tailored in manu-
facturing. For transplantation of cells
into the retina, bucky paper serves si-
multaneously as a substrate for cell
growth and as a barrier for new blood
vessel formation, which can be a prob-
lem in the exudative type of  macular
degeneration.
Bucky paper is easily handled dur-
ing surgical implantation into the eye.
Through appropriate choice of manu-
facturing processes, bucky paper can
be made relatively rigid yet able to
conform to the retina when the bucky
paper is implanted. Bucky paper of-
fers a distinct advantage over other
materials that have been investigated
for retinal cell transplantation — lens
capsule and Descemet’s membrane —
which are difficult to handle during
surgery because they are flimsy and do
not stay flat.
In preparation for implantation, the
selected cells are first cultured onto a
piece of bucky paper. A retinotomy is
then performed, the cell-covered bucky
paper is implanted, and the retina is
reattached.  Because bucky paper does
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Bucky paper supports the cells before, during, and after surgery.
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Figure 1. The Mesh of Carbon Nanotubes in Bucky
Paper can be seen in this high magnification scan-
ning electron micrograph .
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Figure 2. Micrographs of RPE Cells illustrate the following: (a) human RPE cells cultured on bucky
paper, as shown in this scanning electron micrograph, form a monolayer which is suitable for trans-
plantation into the retina and (b) light micrograph of human RPE cells (stained blue) cultured on
bucky paper  (black) viewed in cross section.
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not trigger an inflammatory reaction in
the eye, it can be left in place after trans-
plantation to serve as a basement mem-
brane patch.
The attachment of RPE (see Figure
2), IPE, and/or stem cells onto the
bucky paper may be enhanced by chem-
ically modifying or coating the bucky
paper with one or more biologically ac-
tive substances. The ability to easily
make these modifications may serve as
an important way of optimizing retinal
cell transplantation for macular degen-
eration and retinitis pigmentosa and
may facilitate other ophthalmologic ap-
plications as well.
This patent pending work was performed
by David J. Loftus, Martin Cinke, and
Meyya Meyyappan of Ames Research Cen-
ter, Center for Nanotechnology, and by Har-
vey Fishman, Ted Leng, Philip Huie, and
Kalayaan Bilbao of Stanford University
School of Medicine, Department of Ophthal-
mology. Further information is contained in a
TSP (see page 1).
Inquiries concerning rights for the commer-
cial use of this invention should be addressed
to the Patent Counsel, Ames Research Center,
(650) 604-5104. Refer to ARC-14940.
Using an Ultrasonic Instrument to Size Extravascular Bubbles
Measurements could be used to guide prebreathing of oxygen to reduce the risk of
decompression sickness.
Lyndon B. Johnson Space Center, Houston, Texas
In an ongoing development project,
microscopic bubbles in extravascular tis-
sue in a human body will be detected by
use of an enhanced version of the appa-
ratus described in “Ultrasonic Bubble-
Sizing Instrument” (MSC-22980), NASA
Tech Briefs, Vol. 24, No. 10 (October
2000), page 62. To recapitulate: The
physical basis of the instrument is the
use of ultrasound to excite and measure
the resonant behavior (oscillatory ex-
pansion and contraction) of bubbles.
The resonant behavior is a function of
the bubble diameter; the instrument ex-
ploits the diameter dependence of the
resonance frequency and the general
nonlinearity of the ultrasonic response
of bubbles to detect bubbles and poten-
tially measure their diameters.
In the cited prior article, the applica-
tion given most prominent mention was
the measurement of gaseous emboli (es-
sentially, gas bubbles in blood vessels)
that cause decompression sickness and
complications associated with car-
diopulmonary surgery. According to the
present proposal, the instrument capa-
bilities would be extended to measure
extravascular bubbles with diameters in
the approximate range of 1 to 30 µm.
The proposed use of the instrument
could contribute further to the under-
standing and prevention of decompres-
sion sickness: There is evidence that sug-
gests that prebreathing oxygen greatly
reduces the risk of decompression sick-
ness by reducing the number of micro-
scopic extravascular bubbles. By using
the ultrasonic bubble-sizing instrument
to detect and/or measure the sizes of
such bubbles, it might be possible to pre-
dict the risk of decompression sickness.
The instrument also has potential as a
tool to guide the oxygen-prebreathing
schedules of astronauts; high-altitude
aviators; individuals who undertake
high-altitude, low-opening (HALO)
parachute jumps; and others at risk of
decompression sickness. For example,
an individual at serious risk of decom-
pression sickness because of high con-
centrations of extravascular microscopic
bubbles could be given a warning to con-
tinue to prebreathe oxygen until it was
safe to decompress.
This work was done by Patrick J. Magari,
Robert J. Kline-Schoder, and Marc A. Kenton
of Creare, Inc., for Johnson Space Center.
For further information, contact:
Creare, Inc.
P.O. Box 71
Hanover, NH 03755
Phone: (603) 643-3800
Fax: (603) 643-4657
E-mail: info@creare.com
Refer to MSC-23128.
